The relationship between mild autonomous cortisol secretion and metabolic diseases in cases with adrenal incidentaloma
, 2, 1, 2, 2, 2, 2
Abstract
Introduction: This study investigates the link between mild autonomous cortisol secretion (MACS) in adrenal incidentaloma (AI) patients and the occurrence and severity of cardiovascular and metabolic comorbidities. It aims to provide a detailed overview of this relationship, highlight gaps in current research, and propose directions for future studies.
Material and methods: We conducted a retrospective analysis at Ankara City Hospital’s Endocrine Department outpatient clinic, reviewing 627 AI patients from February 2019 to May 2021. The study involved a detailed analysis of clinical records, hormonal evaluations, and imaging, focusing on differentiating MACS from non-functioning adrenal incidentalomas (NFAI) and examining the impact of MACS on associated health conditions.
Results: The study found that MACS patients had a statistically higher incidence of diabetes mellitus (35% vs. 20%), hypertension (60% vs. 45%), hyperlipidaemia (40% vs. 25%), and coronary artery disease (30% vs. 15%) compared to the NFAI group. Independent predictors of MACS included the presence of bilateral adrenal masses, larger adrenal mass diameter (with a cutoff value of ≥ 18.5 mm, showing 83% sensitivity and 56% specificity for predicting MACS, and lower dehydroepiandrosterone sulphate (DHEAS) levels (≤ 49.31 μg/dL predicting MACS, with 61% sensitivity and 73% specificity).
Conclusion: This research underscores the critical clinical implications of detecting MACS in AI patients, particularly its association with increased cardiovascular and metabolic risks. It calls for vigilant screening and a comprehensive management approach for affected patients. Additionally, the findings highlight the need for further studies to improve patient care and outcomes in this population.
Keywords: adrenal incidentalomasmild autonomous cortisol secretioncardiovascular riskmetabolic comorbiditiesendocrinology
References
- Araujo-Castro M, Sampedro Núñez MA, Marazuela M. Autonomous cortisol secretion in adrenal incidentalomas. Endocrine. 2019; 64(1): 1–13.
- Fassnacht M, Tsagarakis S, Terzolo M, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023; 189(1): G1–G42.
- Minnaar EM, Human KE, Henneman D, et al. An adrenal incidentaloma: how often is it detected and what are the consequences? ISRN Radiol. 2013; 2013: 871959.
- Reimondo G, Castellano E, Grosso M, et al. Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study. J Clin Endocrinol Metab. 2020; 105(4).
- Brunt LM, Moley JF. Adrenal incidentaloma. World J Surg. 2001; 25(7): 905–913.
- Fukuoka H, Shichi H, Yamamoto M, et al. The Mechanisms Underlying Autonomous Adrenocorticotropic Hormone Secretion in Cushing's Disease. Int J Mol Sci. 2020; 21(23).
- Favero V, Cremaschi A, Parazzoli C, et al. Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside. Int J Mol Sci. 2022; 23(2).
- Burford NG, Webster NA, Cruz-Topete D. Hypothalamic-Pituitary-Adrenal Axis Modulation of Glucocorticoids in the Cardiovascular System. Int J Mol Sci. 2017; 18(10).
- Aresta C, Favero V, Morelli V, et al. Cardiovascular complications of mild autonomous cortisol secretion. Best Pract Res Clin Endocrinol Metab. 2021; 35(2): 101494.
- Sbardella E, Minnetti M, D'Aluisio D, et al. Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas. Eur J Endocrinol. 2018; 178(5): 501–511.
- Petramala L, Olmati F, Concistrè A, et al. Cardiovascular and metabolic risk factors in patients with subclinical Cushing. Endocrine. 2020; 70(1): 150–163.
- Morelli V, Reimondo G, Giordano R, et al. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab. 2014; 99(3): 827–834.
- Falcetta P, Orsolini F, Benelli E, et al. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study. Endocrine. 2021; 71(1): 178–188.
- Sbardella E, Minnetti M, D'Aluisio D, et al. Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas. Eur J Endocrinol. 2018; 178(5): 501–511.
- Patrova J, Kjellman M, Wahrenberg H, et al. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center. Endocrine. 2017; 58(2): 267–275.
- Deutschbein T, Reimondo G, Di Dalmazi G, et al. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol. 2022; 10(7): 499–508.
- Araujo-Castro M, Parra P, Martín Rojas-Marcos P, et al. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences? Endocrine. 2019; 66(3): 650–659.
- Athanasouli F, Georgiopoulos G, Asonitis N, et al. Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis. Endocrine. 2021; 74(1): 50–60.
- Araujo-Castro M, Parra Ramírez P, Robles Lázaro C, et al. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas. Hormones (Athens). 2021; 20(4): 735–744.
- Ceccato F, Tizianel I, Voltan G, et al. Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study. Front Endocrinol (Lausanne). 2021; 12: 794197.
- Xiao S, Liu F, Yu L, et al. An epidemiological survey of laryngopharyngeal reflux disease at the otorhinolaryngology-head and neck surgery clinics in China. Eur Arch Otorhinolaryngol. 2020; 277(10): 2829–2838.
- Muangnoo N, Manosroi W, Leelathanapipat N, et al. Predictive Factors of Functioning Adrenal Incidentaloma: A 15-Year Retrospective Study. Medicina (Kaunas). 2022; 58(5).
